Entero Therapeutics Inc (NAS:ENTO) Stock News, Headlines & Updates
Entero Therapeutics Inc Stock News from GuruFocus
- 1
Jul 11, 2024
Entero Therapeutics Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $1.9 Million Gross Proceeds
Marketwired • 7:00am
Jul 09, 2024
Entero Therapeutics Announces Abstract on Celiac Disease Research Accepted for Presentation at the 20th International Celiac Disease Symposium
Marketwired • 6:00am
Jun 27, 2024
Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Intestinal Damage in Celiac Disease
Marketwired • 5:00am
May 22, 2024
Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention
Marketwired • 6:00am
May 20, 2024
Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference
Marketwired • 6:00am
May 16, 2024
First Wave BioPharma Changes Name to Entero Therapeutics
Marketwired • 6:00am
May 10, 2024
First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-Market
Marketwired • 7:00am
May 09, 2024
First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness Month
Marketwired • 6:00am
Apr 24, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news